Wanibuchi Hideki | 大阪府立成人病センター 分子生物学
スポンサーリンク
概要
関連著者
-
Wanibuchi Hideki
大阪府立成人病センター 分子生物学
-
Wanibuchi Hideki
Department Of Pathology Osaka City University Medical School
-
WANIBUCHI Hideki
Department of Pathology, Osaka City University Medical School
-
FUKUSHIMA Shoji
Department of Pathology, Osaka City University Medical School
-
MORIMURA Keiichirou
Department of Pathology, Osaka City University Medical School
-
Morimura K
Department Of Pathology Osaka City University Medical School
-
Morimura Keiichirou
大阪市立大学 医学部都市医学
-
Fukushima S
Japan Bioassay Research Center Japan Industrial Safety And Health Association
-
Wanibuchi Hideki
大阪市立大学 核医
-
Wanibuchi Hideki
Dept. Pathology Osaka City University Medical School
-
Morimura Keiichirou
Department Of Pathology Osaka City University Medical School
-
Wanibuchi Hideki
First Department Of Pathology Osaka City University Medical School
-
FUKUSHIMA Shoji
First Department of Pathology, Osaka City University Medical School
-
Yamamoto S
Department Of Pathology Osaka City University Medical School
-
Wei Min
Department Of Pathology Osaka City University Medical School
-
Yamamoto Shinji
大阪市立大学 病理
-
Murai Takashi
Department Pathology Osaka City University Medical School
-
WEI Min
Department of Pathology, Osaka City University Medical School
-
Yamamoto Shinji
First Department of Pathology Osaka City University Medical School
-
Mori Satoru
大阪市立大学 医学部病理学第1
-
Mori Satoru
Department Pathology Osaka City University Medical School
-
Makino Susumu
Aburahi Laboratories Shionogi Research Laboratories Shionogi & Co. Ltd.
-
Makino Susumu
大阪市立大学 医学部病理学第1
-
WADA Seiji
Department of Urology, Osaka City University Medical School
-
Wada Seiji
Department Of Urology Osaka City University Medical School
-
Wada Seiji
大阪市立大学 医学部病理学
-
NAKAE Dai
Department of Environmental Health and Toxicology, Tokyo Metropolitan Institute of Public Health
-
MORI Yukio
Institute of Biological Pharmacy, Gifu Pharmaceutical University
-
KOIDE Akihiro
Institute of Biological Pharmacy, Gifu Pharmaceutical University
-
Nakae D
Department Of Pathology Sasaki Institute Sasaki Foundation
-
Nakae Dai
Department Of Environmental Health And Toxicology Tokyo Metropolitan Institute Of Public Health
-
Nakatani Tatsuya
Department of Urology, Osaka City University Medical School
-
KOIDE Akihiro
Gifu Pharmaceutical University
-
Hoshi Manabu
大阪市立大学 医学部病理学
-
Nakatani T
Department Of Urology Osaka City University Medical School
-
Nakatani Tatsuya
大阪市立大学 医学部臓器器官病態外科学
-
Mori Yukio
Institute Of Biological Pharmacy Gifu Pharmaceutical University
-
Morimura Keiichirou
First Department of Pathology Osaka City University Medical School
-
Nakae D
Department Of Environmental Health And Toxicology Tokyo Metropolitan Institute Of Public Health:toky
-
MORI Yukio
Gifu Pharmaceutical University
-
MITSUHASHI Makoto
Department of Pathology, Osaka City University Medical School
-
MASUDA Chikayoshi
Department of Urology, Osaka City University Medical School
-
Masuda Chikayoshi
Department Of Urology Osaka City University Medical School
-
Mitsuhashi Makoto
Department Of Pathology Osaka City University Medical School
-
Lee Chyi
First Department of Pathology Osaka City University Medical School
-
Morishita Y
First Department Of Pathology Gifu University School Of Medicine
-
Yanai T
Department Of Veterinary Pathology Gifu University
-
Totsuka Yukari
大阪府立大学先端科学イノベーションセンター 遺伝子環境科学研究室
-
Totsuka Y
Cancer Prevention Basic Research Project
-
MURAI Takashi
First Department of Pathology, Osaka City University Medical School
-
Makino Susumu
Aburahi Laboratories Shionogi & Co. Ltd.
-
KITANO Mitsuaki
First Department of Pathology, Osaka City University Medical School
-
KANG JIN
Department of Pediatrics, The Catholic University of Korea
-
Ichihara Toshio
Department Of Pathology Osaka City University Medical School
-
Ichihara T
Department Of Physics Graduate School Of Science Osaka University
-
Ichihara Toshio
大阪市立大学 病理
-
MURAI Takashi
Department of Pathology, Osaka City University Medical School
-
Nakatani Tatsuya
大阪市立大学 医研究臓器器官病態外
-
Kishimoto Taketoshi
Department of Urology Osaka City University Medical School
-
Kang Jin
Department Of Pathology Osaka City University Medical School
-
PUATANACHOKCHAI Rawiwan
Department of Pathology, Osaka City University Medical School
-
Totsuka Yukari
Cancer Prevention Basic Research Project National Cancer Center Research Institute
-
Kim Taku
大阪市立大学 泌
-
MAKINO Susumu
Aburahi Laboratories Shionogi Research Laboratories
-
MORI Satoru
First Department of Pathology, Osaka City University Medical School
-
MIN Wei
Department of Pathology, Osaka City University Medical School
-
YANO Yoshihisa
Second Department of Biochemistry, Osaka City University Medical School
-
OTANI Shuzo
Second Department of Biochemistry, Osaka City University Medical School
-
Kang Jin
Department Of Biomedical Laboratory Science Namseoul Univeristy
-
HAGIWARA Akihiro
DIMS Institute of Medical Science, Inc.
-
小西 陽一
奈良県立医科大学腫瘍病理
-
YAMAMOTO Shinji
Department of Neurosurgery, Kyoto Second Red Cross Hospital
-
高橋 通正
(独)産業技術総合研究所 環境管理技術研究部門
-
Yamamoto Shinji
Department Of Animal Husbandry Faculty Of Agriculture Tohoku University:(present Address) Department
-
TOTSUKA Yukari
Cancer Prevention Division, National Cancer Center Research Institute
-
Hagiwara A
Dims Institute Of Medical Science Inc.
-
Hagiwara Akihiro
Dims医科学研究所
-
Hagiwara Akihiro
大阪市立大学 医学部病理学第1
-
Hagiwara Akihiro
Dims Inst. Medical Sci. Inc.
-
Konishi Y
Department Of Oncological Pathology Cancer Center Nara Medical University
-
Takahashi M
National Inst. Health Sci. Tokyo
-
Kakizoe Tadao
Department Of Orthopaedic Surgery Osaka City University Medical School
-
SALIM Elsayed
Department of Pathology, Osaka City University Medical School
-
Salim E
Department Of Pathology Osaka City University Medical School
-
Salim Elsayed
大阪市立大学 医学部病理学
-
Salim Elsayed
Department Of Pathology Osaka City University Medical School
-
Yamamoto Keiswke
Department of Urology Osaka City University Medical School
-
Hayashi S
Department Of Pathology Tokyo Metropolitan Komagome Hospital
-
Horiguchi Shinichiro
鳥取大学 医学部病態解析医学講座医用放射線学
-
高橋 通正
神奈川県環境科セ
-
HAYASHI Shin-ichi
Saitama Cancer Center Research Institute
-
MORI Satoru
Department of Pathology, Osaka City University Medical School
-
Hayashi S
Department Of Pathology Osaka City University Medical School
-
Konishi Yoichi
International Federation Of Societies Of Toxicologic Pathologists
-
Tatematsu M
Division Of Oncological Pathology Aichi Cancer Center Research Institute
-
TATEMATSU Masae
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
KONISHI Yoichi
Department of Oncological Pathology, Cancer Center, Nara Medical University
-
TSUDA Hiroyuki
Experimental Pathology and Chemotherapy Division, National Cancer Center Research Institute
-
Hagiwara Akihiro
Department Pathology Osaka City University Medical School
-
ICHIHARA Toshio
Department of Experimental Pathology and Tumor Biology, Nagoya City University Graduate School of Me
-
Ichihara Toshio
Dims医科学研究所
-
Konishi Yoichi
奈良県立医科大学附属がんセンター 腫瘍病理学
-
KAKUNI Masakazu
Department of Pathology, Osaka City University Medical School
-
Nakamura Takahiro
Department Of Radiation Biology Graduate School Of Medicine Osaka University
-
Masuda Chikayoshi
First Department of Pathology Osaka City University Medical School
-
Ikemoto Shinichi
Department of Urology Osaka City University Medical School
-
Sugimura Kazunobu
Department of Urology Osaka City University Medical School
-
KUSHIDA Masahiko
Department of Veterinary Pharmacology, Graduate School of Agriculture and Life Sciences, Osaka Prefe
-
HAYASHI Shuji
Department of Safety Assessment, Fuji Gotemba Research Laboratory, Chugai Pharmaceutical Co., Ltd.
-
Chen Tianxin
大阪市立大学 医学部都市医学
-
Chen T
First Department Of Pathology Osaka City University Medical School
-
Ogawa Motome
大阪市立大学 病理
-
Ogawa Motome
Department Of Pathology Osaka City University Medical School
-
Tatematsu Masae
Division Of Oncological Pathology Aichi Cancer Center Research Institute
-
KOIDE Akihiro
Laboratory of Radiochemistry, Gifu Pharmaceutical University
-
KIYOTA Atsuhiko
Department of Urology, Osaka City University Medical School
-
KIKUZAKI Hiroe
Laboratory of Food Chemistry, Department of Food and Nutrition Faculty of Science of Living, Osaka C
-
NAKATANI Nobuji
Laboratory of Food Chemistry, Department of Food and Nutrition Faculty of Science of Living, Osaka C
-
Fukushima Shoji
Japan Bioassay Research Center, Japan Industrial Safety and Health Association
-
ICHIHARA Toshio
First Department of Pathology, Osaka City University Medical School
-
Hayashi Shuji
Department Of Neurosurgery Fukuoka University Faculty Of Medicine
-
高橋 正好
(独)産業技術総合研究所 環境管理技術研究部門
-
Hirose Masao
Division of Pathology, National Institute of Health Sciences
-
小西 陽一
奈良医大
-
Hirose Masao
Food Safety Commission, Cabinet Office, Government of Japan
-
Tada Mitsuhiro
Division Of Cancer-related Genes Institute For Genetic Medicine Hokkaido University
-
Mori H
Division Of Pathology National Institute Of Health Sciences
-
Inada Ken-ichi
Department Of Pathology Fujita Health University School Of Medicine
-
FURUKAWA Fumio
Division of Pathology, National Institute of Health Sciences
-
TAKAHASHI Satoru
Department of Experimental Pathology and Tumor Biology, Nagoya City University Graduate School of Me
-
TATEMATSU Kenjiro
Institute of Biological Pharmacy, Gifu Pharmaceutical University
-
HIROSE Masao
Department of Pathology, Kangwon National University
-
FUNAE Yoshihiko
Department of Chemical Biology, Osaka City University Graduate School of Medicine
-
HOSHI Manabu
Department of Orthopedic Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Researc
-
Tsukamoto T
Division Of Oncological Pathology Aichi Cancer Center Research Institute
-
TSUKAMOTO Tetsuya
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
WAKABAYASHI Keiji
Cancer Prevention Division, National Cancer Center Research Institute
-
IKEHARA Yuzuru
Divisions of Oncological Pathology, Aichi Cancer Center Research Institute
-
UEHARA Nobuaki
Experimental Pathology and Chemotherapy Division, National Cancer Center Research Institute
-
IMAIDA katsumi
Department of Pathology, Nagoya City University Medical School
-
SHIRAI Tomoyuki
Department of Pathology, Nagoya City University Medical School
-
IMAIDA Katsumi
Onco-Pathology, Faculty of Medicine, Department of Pathology and Host-Defense, Kagawa University
-
KAKIZOE Tadao
National Cancer Center Hospital
-
HAGIWARA Akihiro
Daiyu-kai Institute of Medical Science
-
NOMURA Taisei
Department of Radiation Biology and Medical Genetics, Graduate School of Medicine, Osaka University
-
Imaida K
Onco-pathology Faculty Of Medicine Department Of Pathology And Host-defense Kagawa University
-
Imaida Katsumi
国立がんセンター研究所 がん予防基礎研究プロジェクト
-
Imaida Katsumi
大雄会医科学研究所
-
Imaida Katsumi
Department Of Onco-pathology Faculty Of Medicine Kagawa University
-
TAKAOKA Kunio
Department of Orthopaedic Surgery, Osaka City University Graduate School of Medicine
-
SEKI Shuichi
Department of Hepatology, Graduate School of Medicine, Osaka City University
-
NIWA Toru
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
NAKANISHI Hayao
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
Nakamura Takahiro
Department of Pediatrics and Child Health, Nihon University School of Medicine
-
Morimura Keiichiro
Department of Surgery, Osaka City Juso Hospital
-
SENOH Hideki
Department of Pathology, Japan Bioassay Research Center
-
TAKABA Katsumi
Department of Pathology, Osaka City University Medical School
-
NAGANO Kasuke
Department of Pathology, Japan Bioassay Research Center
-
I. Salim
First Department Of Pathology Osaka City University Medical School
-
Hoshi Manabu
Department Of Pathology Osaka City University Medical School
-
Furukawa F
Division Of Pathology National Institute Of Health Sciences
-
Furukawa Fumio
国立衛生試験所
-
Furukawa Fumio
Division Of Pathology National Institute Of Health Sciences
-
YOSHIMURA Isao
Faculty of Engineering, Tokyo University of Science
-
Inada Ken-ichi
愛知県がんセンター研究所 腫瘍病理学部
-
Kasai Y
Dept Gastroenterological Surgery Nagoya Univ.
-
Kasai Yasushi
名古屋大学 医学部第2内科
-
Nishisaka Nobuyasu
Department of Urology Osaka City University Medical School
-
YAMACHIKA Takasuke
Division of Oncological Pathology, Aichi Cancer Center Research Institute
-
YASUI Kenzo
Department of Gastroenterological Surgery, Aichi Cancer Center Hospital
-
Mori Hideki
岐阜薬科大学 生物薬学研究所
-
Makita Hiroki
岐阜大学 第1病理
-
稲田 健一
Department Of Pathology Fujita Health University School Of Medicine
-
HAGIHARA Atsushi
Department of Pathology, Osaka City University Medical School
-
MIYAZI Natsuko
Department of Pathology, Osaka City University Medical School
-
Wakabayashi Keiji
Cancer Prevention Basic Research Project National Cancer Center Research Institute
-
Uehara Nobuaki
Experimental Pathology And Chemotherapy Division National Cancer Center Research Institute
-
HAYASHI Yutaro
Department of Biochemistry, Kyorin University School of Medicine
-
Miyauchi Hideyuki
Developmental Research Laboratories Shionogi & Co. Ltd.
-
INOUE Satoshi
Developmental Research Laboratories, Shionogi & Co., Ltd.
-
MARUYAMA Toshiyuki
Developmental Research Laboratories, Shionogi & Co., Ltd.
-
MORI Yukio
Laboratory of Radiochemistry, Gifu Pharmaceutical University
-
Tatematsu M
愛知県がんセンター研究所 腫瘍病理学部
-
IMAOKA Susumu
Laboratory of Chemistry, Osaka City University Medical School
-
FUNAE Yoshihiko
Laboratory of Chemistry, Osaka City University Medical School
-
HAYASHI Shuji
First Department of Pathology, Osaka City University Medical School
-
Tsukamoto Tetsuya
Division Of Oncological Pathology Aichi Cancer Center Research Institute
-
Morimura Keiichiro
Department Of Surgery Osaka City Juso Hospital
-
Seki Shuichi
Department Of Cardiology Chikamori Hospital
-
Hirose Masao
Division Of Pathology National Institute Of Health Sciences
-
Vijayaraghavan Meenakshi
Department of Pathology, Osaka City University Medical School, Abeno-ku, Osaka 545-8585, Japan
-
Hakoi Katsuo
Department of Pathology, Osaka City University Medical School, Abeno-ku, Osaka 545-8585, Japan
-
HORI Takaaki
First Department of Pathology, Osaka City University Medical School
-
MEENAKSHI Vijayaraghavan
First Department of Pathology, Osaka City University Medical School
-
Sukata Tokuo
Environmental Health Science Lab. Sumitomo Chemical Co. Ltd.
-
Senoh Hideki
Japan Bioassay Research Center Japan Industrial Safety And Health Association
-
Hoshi Manabu
Department Of Orthopaedic Surgery Osaka Medical Center For Cancer And Cardiovascular Diseases
-
Nagano Kasuke
Japan Bioassay Research Center Japan Industrial Safety And Health Association
-
長野 嘉介
Division Of Pathology Japan Bioassay Research Center
-
Kakizoe Tadao
National Cancer Center
著作論文
- Lack of a Dose-response Relationship for Carcinogenicity in the Rat Liver with Low Doses of 2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline or N-Nitrosodiethylamine
- Absence of β-catenin Mutations in Mouse Hepatoblastomas Induced by N,N-dimethylformamide
- Carcinogenic Potential of 2-Amino-3-methylimidazo[4,5-f]quinoline (IQ) in Severe Combined Immunodeficient (SCID) Mice
- Lack of Inhibition of BBN-induced Bladder Carcinogenesis in C57BL/6 Mice by Intravesical Instillation of KRN 7000
- P6-02 Enhancement of thioacetamide-induced liver cirrhosis by estradiol 3-benzoate in the rats(LIVER AND DIGESTIVE SYSTEM/CIRCULATORY SYSTEM-1/DEVELOPMENT AND REPRODUCTION)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- Carcinogenicity of Dimethylarsinic Acid in F344 Rats and p53 (+/-) Knockout and Wild Type C57BL/6J Mice. Relevance with Genetic Alterations and Oxidative DNA Damage (CARCINOGENICITY) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual
- Significance of Cyclin D1 Overexpression in Transitional Cell Carcinomas of the Urinary Bladder and its Correlation with Histopathological Features
- Establishment and characterization of a human colonic mucinous carcinoma cell line with predominant goblet-cell differentiation from liver metastasis
- Existence of a no effect level for MeIQx hepatocarcinogenicity on a background of thioacetamide-induced liver damage in rats
- Differences in Sensitivity of F344 Rats from Different Breeders to Phenobarbital Hepatocarcinogenicity
- Differences in susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis between SD/gShi rats with spontaneous hypospermatogenesis and SD/cShi rats with spontaneous hydronephrosis
- Promoting Effect of Sodium L-Ascorbate on N-Butyl-N-(4-hydroxybutyl)nitrosamine-induced Renal Pelvic Carcinogenesis in SD/cShi Rats of Both Sexes
- Lack of changes in the levels of liver and kidney cytochrome P-450 isozymes in p53(+/-)knockout mice treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
- Differences among Three Sister Strains of NON/Shi Mice in Sensitivity to Urinary Tract Carcinogenesis by N-Butyl-N-(4-hydroxybutyl)nitrosamine.
- High Susceptibility of p53(+/-)Knockout Mice in N-Butyl-N-(4-hydroxybutyl)nitrosamine Urinary Bladder Carcinogenesis and Lack of Frequent Mutation in Residual Allele.
- Di-n-butyl Phthalate is Toxic to the Male Reproductive System and Its Toxicity is Enhanced by Thioacetamide Induced Liver Injury
- Food Restriction Inhibits the Growth of Intestinal Polyps in Multiple Intestinal Neoplasia Mouse
- Chemopreventive Effects of Coumaperine from Pepper on the Initiation Stage of Chemical Hepatocarcinogenesis in the Rat
- Possible Involvement of Adaptation Mechanisms in the Achievement of an Ineffective Dose Range for the Carcinogenicity of Genotoxic Carcinogens
- Induction of DNA-adducts and increase of 8-hydroxy-2-deoxyguanosine, but no development of preneoplastic lesions in offspring liver with transplacental and trans-breast milk exposure to 2-amino-3, 8-dimethylimidazo [4, 5-f] quinoxaline (MeIQx) in rats
- Promotion of Rat Hepatocarcinogenesis by Dimethylarsinic Acid : Association with Elevated Ornithine Decarboxylase Activity and Formation of 8-Hydroxydeoxyguanosine in the Liver
- p53 and H-ras Mutations and Microsatellite Instability in Renal Pelvic Carcinomas of NON/Shi Mice Treated with N-Butyl-N-(4-hydroxybutyl)-nitrosamine: Different Genetic Alteration from Urinary Bladder Carcinoma
- Inhibitory Effects of S-Methylcysteine and Cysteine on the Promoting Potential of Sodium Phenobarbital on Rat Liver Carcinogenesis
- p53 in Multiple Human Urothelial Cancers: Assessment for Clonality by the Yeast p53 Functional Assay in Combination with p53 Immunohistochemistry
- Loss of Heterozygosity in (Lewis×F344)F_1 Rat Urinary Bladder Tumors Induced with N-Butyl-N-(4-hydroxybutyl) nitrosamine Followed by Dimethylarsinic Acid or Sodium L-Ascorbate
- Molecular cytogenetic identification of cyclin D1 gene amplification in a renal pelvic tumor attributed to phenacetin abuse
- Urinary Bladder Lesions after the Chernobyl Accident : Immunohistochemical Assessment of p53, Proliferating Cell Nuclear Antigen, Cyclin D1 and p21^
- Promotion by Sodium L-Ascorbate in Rat Two-stage Urinary Bladder Carcinogenesis is Dependent on the Interval of Administration
- Cyclin D1 Overexpression in Rat Two-Stage Bladder Carcinogenesis and its Relationship with Oncogenes, Tumor Suppressor Genesand Cell Proliferation
- Inhibition of Development of N,N'-Dimethylhydrazine-induced Rat Colonic Aberrant Crypt Foci by Pre, Post and Simultaneous Treatments with 24R ,25-Dihydroxyvitamin D_3
- Susceptibility of Four F_1 Hybrids of Male Rats to the Promoting Effects of Sodium L-ascorbate in Two-Stage Urinary Bladder Carcinogenesis
- Chemopreventive Effects of Bovine Lactoferrin on N-Butyl-N-(4-hydroxybutyl)nitrosamine-induced Rat Bladder Carcinogenesis
- Existence of a Threshold for the Genotoxic Carcinogens : Evidence from Mechanism-based Carcinogenicity Studies
- Ethanol Does Not Promote MeIQx-initiated Rat Colon Carcinogenesis Based on Evidence from Analysis of a Colon Cancer Surrogate Marker
- Upregulation of fibroblast growth factor receptor 3 and epidermal growth factor receptors, in association with Raf-1, in urothelial dysplasia and carcinoma in situ after the Chernobyl accident
- Hormesis in Carcinogenicity of Non-genotoxic Carcinogens
- Possible tumor development from double positive foci for TGF-alpha and GST-P observed in early stages on rat hepatocarcinogenesis
- Aberrant expression of E-cadherin and β-catenin in association with transforming growth factor-β1 in urinary bladder lesions in humans after the Chernobyl accident
- Dose-dependence of promotion of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline-induced rat hepatocarcinogenesis by ethanol : Evidence for a threshold
- Examination of the Rat Model of Liver Injury via Thioacetamide (TAA) or Carbon Tetrachloride (CCl_4)
- Significance of overexpression of metallothionein in mouse urinary bladder focal lesions induced by treatment with N-butyl-N-(4-hydroxybutyl)-nitrosamine
- Urinary bladder lesions induced by persistent chronic low-dose ionizing radiation
- Lack of Inhibitory Effects of an Anti-angiogenesis Drug, TNP-470, on Rat Urinary Bladder Papillomatosis Induced by Mechanical Stimulation
- Promotion of Skin Carcinogenesis by Dimethylarsinic Acid in Keratin (K6)/ODC Transgenic Mice
- Lack of Inhibitory Effects of Coumaperine from Pepper on the Promotion Stage of Chemical Hepatocarcinogenesis in the Rat
- Inhibitory effect of phenobarbital at low dose on rat hepatocarcinogenesis : the evidence for hormesis (CARCINOGENICITY) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Thresholds for Carcinogenicity of Environmental Carcinogens (SYMPOSIUM3: RECENT TOPICS ON THE RISK ASSESSMENT OF CHEMICAL CARCINOGENS) (Proceedings of the 30th Annual Meeting)
- Lack of Influence of Testicular Castration or Sialoadenectomy on Sodium L-Ascorbate Promotion of Urinary Bladder Carcinogenesis in Male F344 Rats
- Strain Differences in Sensitivity to the Promoting Effect of Sodium L-Ascorbate in a Two-stage Rat Urinary Bladder Carcinogenesis Model
- LACK OF INHIBITORY EFFECTS OF THE JU-MYO PROTEIN ON DEVELOPMENT OF GLUTATHIONE S-TRANSFERASE PLACENTAL FORM-POSITIVE FOCI IN THE MALE F344 RAT LIVER
- S-Methylcysteine and Cysteine Are Inhibitors of Induction of Glutathione S-Transferase Placental Form-positive Foci during Initiation and Promotion Phases of Rat Hepatocarcinogenesis
- Low-dose carcinogenicity of 2-amino-3-methylimidazo[4,5-f]quinoline in rats : Evidence for the existence of no-effect levels and a mechanism involving p21^
- AGR2 as a Potential Biomarker of Human Lung Adenocarcinoma
- Differences Among Three Sister Strains of NON/Shi Mice in Sensitivity to Urinary Tract Carcinogenesis by N-Butyl-N-(4-hydroxybutyl)nitrosamine
- Lack of Promoting Potential of Dimethylarsinic Acid in the Kidney of Male NCI-Black Reiter Rats
- Characteristic Upregulation of Glucose-Regulated Protein 78 in an Early Lesion Negative for Hitherto Established Cytochemical Markers in Rat Hepatocarcinogenesis
- Ethanol Does Not Promote MeIQx-initiated Rat Colon Carcinogenesis Based on Evidence from Analysis of a Colon Cancer Surrogate Marker
- Enhanced Urinary Bladder, Liver and Colon Carcinogenesis in Zucker Diabetic Fatty Rats in a Multiorgan Carcinogenesis Bioassay : Evidence for Mechanisms Involving Activation of PI3K Signaling and Impairment of p53 on Urinary Bladder Carcinogenesis
- Evaluation of the Subchronic Toxicity of Dietary Administered Equisetum arvense in F344 Rats
- Morphological Changes in Silver-stained Nucleolar Organizer Regions (AgNORs) Related to Proliferative Activity in Glutathione S-transferase Placental Form (GST-P) Positive Foci of Rat Liver